Novartis

$87.43
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.93 (+1.08%) Today
$0.00 (0.00%) As of 11:41 PM UTC after-hours

Why Robinhood?

You can buy or sell Novartis and other stocks, options, and ETFs commission-free!

About NVS

Novartis AG, also called Novartis, is a holding company, which engages in the development, manufacture, and marketing of healthcare products. It operates through the following segments: Innovative Medicines, Sandoz, and Corporate. The Innovative Medicines segment researches, develops, manufactures, distributes and sells patented pharmaceuticals, and is composed of two business units: Novartis Oncology and Novartis Pharmaceuticals. The Sandoz segment develops, manufactures and markets finished dosage form medicines as well as intermediary products including active pharmaceutical ingredients. The Corporate segment refers to group management and central services. The company was founded on February 29, 1996 and is headquartered in Basel, Switzerland. The listed name for NVS is Novartis AG.

CEO
Vasant Narasimhan
Employees
105,794
Headquarters
Basel, Basel-Stadt (Basle Town)
Founded
1996
Market Cap
217.21B
Price-Earnings Ratio
24.65
Dividend Yield
2.28
Average Volume
2.08M
High Today
$87.72
Low Today
$86.67
Open Price
$87.17
Volume
2.57M
52 Week High
$98.52
52 Week Low
$69.18

NVS Earnings

$0.00
$0.52
$1.04
$1.56
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
— per share
Actual
Available Apr 27, Pre-Market

You May Also Like

UAE
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure